Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients. Porto DM, Costa GJ, Torres LC, Casarini DE, et al. J Surg Oncol 2024 Jul 7. doi: 10.1002/jso.27763.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Porto DM, Costa GJ, Torres LC, Casarini DE, et al. Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients. J Surg Oncol 2024 Jul 7. doi: 10.1002/jso.27763.
PMID: 38973141